| Year |
Citation |
Score |
| 2022 |
Dusetzina SB, Sarpatwari A, Carrier MA, Hansen RA, Keating NL, Huskamp HA. Patient and Payer Incentives to Use Patented Brand-Name Drugs vs Authorized Generic Drugs in Medicare Part D. Jama Internal Medicine. 181: 1605-1611. PMID 34661600 DOI: 10.1001/jamainternmed.2021.5997 |
0.483 |
|
| 2020 |
Chou C, McDaniel CC, Abrams JD, Farley JF, Hansen RA. An Examination of Prescribing Responsibilities between Psychiatrists and Primary Care Providers. The Psychiatric Quarterly. PMID 32829447 DOI: 10.1007/S11126-020-09828-0 |
0.311 |
|
| 2020 |
Chen L, Li C, Huo N, Mishuk AU, Hansen RA, Harris I, Kiptanui Z, Qian J. Oral generic tacrolimus initiation and substitution in the Medicaid population: a new user cohort study. Current Medical Research and Opinion. 1. PMID 32644886 DOI: 10.1080/03007995.2020.1793750 |
0.304 |
|
| 2020 |
Potthoff K, Stötzer O, Söling U, Hansen R, Harde J, Dille S, Nusch A, Marschner N. Effectiveness and Tolerability of Nab-paclitaxel in Younger versus Elderly Patients With Metastatic HR-positive/HER2-negative Breast Cancer: Results From the Noninterventional, Prospective Study NABUCCO. Clinical Breast Cancer. 20. PMID 32273207 DOI: 10.1016/J.Clbc.2019.11.003 |
0.304 |
|
| 2020 |
Rahman MM, Howard G, Qian J, Garza K, Abebe A, Hansen R. Disparities in the appropriateness of medication use: Analysis of the REasons for Geographic And Racial Differences in Stroke (REGARDS) population-based cohort study. Research in Social & Administrative Pharmacy : Rsap. PMID 32098707 DOI: 10.1016/J.Sapharm.2020.02.008 |
0.308 |
|
| 2019 |
Hohmann NS, Garza KB, Surry D, Hansen RA, Harris I, Kiptanui Z, Oguntimein O, Frost MM, Qian J. Healthcare provider opinions about a generic drug educational newsletter: A pilot cross-sectional survey. Research in Social & Administrative Pharmacy : Rsap. PMID 31838057 DOI: 10.1016/J.Sapharm.2019.12.001 |
0.324 |
|
| 2019 |
Lin YT, Lu TS, Hansen RA, Wang CC. Selective Serotonin Reuptake Inhibitor Use and Risk of Arrhythmia: A Nationwide, Population-Based Cohort Study. Clinical Therapeutics. 41: 1128-1138.e8. PMID 31178037 DOI: 10.1016/J.Clinthera.2019.04.023 |
0.313 |
|
| 2019 |
Hohmann NS, Garza KB, Surry D, Hansen RA, Harris I, Kiptanui Z, Oguntimein O, Frost MM, Qian J. Communicating benefits and risks of generic drugs to consumers: Patient and caregiver opinions of two FDA-developed educational materials. Research in Social & Administrative Pharmacy : Rsap. PMID 30744957 DOI: 10.1016/J.Sapharm.2019.01.013 |
0.337 |
|
| 2018 |
Fahim SM, Mishuk AU, Cheng N, Hansen R, Calderón AI, Qian J. Adverse event reporting patterns of concomitant botanical dietary supplements with CYP3A4 interactive & CYP3A4 non-interactive anticancer drugs in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS). Expert Opinion On Drug Safety. PMID 30576263 DOI: 10.1080/14740338.2019.1562546 |
0.306 |
|
| 2018 |
Hohmann N, Hansen R, Garza KB, Harris I, Kiptanui Z, Qian J. Association between Higher Generic Drug Use and Medicare Part D Star Ratings: An Observational Analysis. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 21: 1186-1191. PMID 30314619 DOI: 10.1016/J.Jval.2018.03.005 |
0.316 |
|
| 2018 |
Marschner N, Salat C, Söling U, Hansen R, Grebhardt S, Harde J, Nusch A, Potthoff K. Final Effectiveness and Safety Results of NABUCCO: Real-World Data From a Noninterventional, Prospective, Multicenter Study in 697 Patients With Metastatic Breast Cancer Treated With nab-Paclitaxel. Clinical Breast Cancer. 18. PMID 30100104 DOI: 10.1016/J.Clbc.2018.07.010 |
0.305 |
|
| 2018 |
Qian J, Mishuk AU, Hansen RA. Does public perception bias lead to more frequent reporting of adverse events: branded vs generic drugs. Expert Opinion On Drug Safety. 1-4. PMID 30052091 DOI: 10.1080/14740338.2018.1503648 |
0.319 |
|
| 2018 |
Sonawane KB, Cheng N, Hansen RA. Serious Adverse Drug Events Reported to the FDA: Analysis of the FDA Adverse Event Reporting System 2006-2014 Database. Journal of Managed Care & Specialty Pharmacy. 24: 682-690. PMID 29952714 DOI: 10.18553/Jmcp.2018.24.7.682 |
0.304 |
|
| 2018 |
Mishuk AU, Qian J, Howard JN, Harris I, Frank G, Kiptanui Z, Hansen R. The Association Between Patient Sociodemographic Characteristics and Generic Drug Use: A Systematic Review and Meta-analysis. Journal of Managed Care & Specialty Pharmacy. 24: 252-264. PMID 29485953 DOI: 10.18553/Jmcp.2018.24.3.252 |
0.335 |
|
| 2018 |
Kiptanui Z, Dowell P, Ogbenna B, Desai K, Zenilman D, Harris I, Qian J, Hansen R. Consistency of Drug Labels for Therapeutically Equivalent Medications Value in Health. 21: S94. DOI: 10.1016/J.Jval.2018.04.633 |
0.337 |
|
| 2017 |
Stirratt MJ, Curtis JR, Danila MI, Hansen R, Miller MJ, Gakumo CA. Advancing the Science and Practice of Medication Adherence. Journal of General Internal Medicine. PMID 29204969 DOI: 10.1007/S11606-017-4198-4 |
0.325 |
|
| 2017 |
Alatawi Y, Rahman MM, Cheng N, Qian J, Peissig PL, Berg RL, Page CD, Hansen RA. Brand vs generic adverse event reporting patterns: An authorized generic-controlled evaluation of cardiovascular medications. Journal of Clinical Pharmacy and Therapeutics. PMID 29092097 DOI: 10.1111/Jcpt.12646 |
0.344 |
|
| 2017 |
Rahman MM, Alatawi Y, Cheng N, Qian J, Peissig PL, Berg RL, Page DC, Hansen RA. Methodological Considerations for Comparison of Brand Versus Generic Versus Authorized Generic Adverse Event Reports in the US Food and Drug Administration Adverse Event Reporting System (FAERS). Clinical Drug Investigation. PMID 28933038 DOI: 10.1007/S40261-017-0574-4 |
0.305 |
|
| 2017 |
Howard JN, Harris I, Frank G, Kiptanui Z, Qian J, Hansen R. Influencers of generic drug utilization: A systematic review. Research in Social & Administrative Pharmacy : Rsap. PMID 28814375 DOI: 10.1016/J.Sapharm.2017.08.001 |
0.332 |
|
| 2017 |
Rahman MM, Alatawi Y, Cheng N, Qian J, Plotkina AV, Peissig PL, Berg RL, Page D, Hansen RA. Comparison of brand versus generic antiepileptic drug adverse event reporting rates in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS). Epilepsy Research. 135: 71-78. PMID 28641219 DOI: 10.1016/J.Eplepsyres.2017.06.007 |
0.31 |
|
| 2017 |
Deshmukh KBS, Qian J, Garza KB, Wright BM, Zeng P, Cazaban CMG, Hansen RA. Health Care Costs Associated with Addition, Titration, and Switching Antihypertensive Medications After First-Line Treatment: Results from a Commercially Insured Sample. Journal of Managed Care & Specialty Pharmacy. 23: 691-699. PMID 28530527 DOI: 10.18553/Jmcp.2017.23.6.691 |
0.307 |
|
| 2017 |
Qian J, Hansen RA, Surry D, Howard J, Kiptanui Z, Harris I. Disclosure of industry payments to prescribers: industry payments might be a factor impacting generic drug prescribing. Pharmacoepidemiology and Drug Safety. PMID 28485111 DOI: 10.1002/Pds.4224 |
0.312 |
|
| 2017 |
Alatawi YM, Hansen RA. Empirical estimation of under-reporting in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS). Expert Opinion On Drug Safety. PMID 28447485 DOI: 10.1080/14740338.2017.1323867 |
0.305 |
|
| 2017 |
Farley JF, Hansen RA, Domino ME, Borse M, Mahendraratnam N, Ray N, Maciejewski ML. Continuity of medication management in Medicaid patients with chronic comorbid conditions: An examination by mental health status. General Hospital Psychiatry. 45: 25-31. PMID 28274335 DOI: 10.1016/J.Genhosppsych.2016.12.001 |
0.325 |
|
| 2017 |
Hansen RA, Qian J, Berg R, Linneman J, Seoane-Vazquez E, Dutcher SK, Raofi S, David Page C, Peissig P. Comparison of Generic-to-Brand Switchback Rates Between Generic and Authorized Generic Drugs. Pharmacotherapy. PMID 28152215 DOI: 10.1002/Phar.1908 |
0.308 |
|
| 2016 |
Hansen RA, Qian J, Berg RL, Linneman JG, Seoane-Vazquez E, Dutcher S, Raofi S, Page CD, Peissig PL. Comparison of outcomes following a switch from a brand to an authorized vs. independent generic drug. Clinical Pharmacology and Therapeutics. PMID 27981563 DOI: 10.1002/Cpt.591 |
0.343 |
|
| 2016 |
Sonawane Deshmukh KB, Qian J, Garza KB, Wright BM, Zeng P, Ganduglia Cazaban CM, Hansen RA. Achieving Adherence After First-Line Antihypertensive Treatment: Should Fixed-Dose Combinations Receive Priority? Journal of Clinical Hypertension (Greenwich, Conn.). PMID 26917089 DOI: 10.1111/Jch.12799 |
0.377 |
|
| 2016 |
Sonawane KB, Qian J, Garza KB, Wright BM, Zeng P, Ganduglia-Cazaban CM, Hansen RA. Patterns of treatment modifications among newly treated hypertensive patients: does choice of modification strategy affect likelihood of treatment discontinuation? Journal of Hypertension. 34: 548-57. PMID 26820480 DOI: 10.1097/Hjh.0000000000000806 |
0.327 |
|
| 2016 |
Hohmann N, Hastings T, Jeminiwa R, Garza K, Qian J, Hansen R. Proposal for a Cross-Sectional Survey to Explore Preferences for and Perceptions of Medication Adherence Incentives Among Patients Taking Medication for a Chronic Disease Research in Social and Administrative Pharmacy. 12: e13-e14. DOI: 10.1016/J.Sapharm.2016.05.032 |
0.307 |
|
| 2015 |
Garza KB, Owensby JK, Braxton Lloyd K, Wood EA, Hansen RA. Pilot Study to Test the Effectiveness of Different Financial Incentives to Improve Medication Adherence. The Annals of Pharmacotherapy. PMID 26447193 DOI: 10.1177/1060028015609354 |
0.306 |
|
| 2015 |
Qian J, Wittayanukorn S, McGuffey G, Hansen R. Factors associated with psychotropic prescriptions, psychiatric hospitalization, and spending among Medicare beneficiaries under 65. Disability and Health Journal. 8: 424-33. PMID 25890881 DOI: 10.1016/J.Dhjo.2015.03.005 |
0.302 |
|
| 2015 |
Hansen RA, Voils CI, Farley JF, Powers BJ, Sanders LL, Sleath B, Maciejewski ML. Prescriber continuity and medication adherence for complex patients. The Annals of Pharmacotherapy. 49: 293-302. PMID 25549627 DOI: 10.1177/1060028014563266 |
0.306 |
|
| 2015 |
Sonawane KB, Qian J, Hansen RA. Utilization patterns of antihypertensive drugs among the chronic kidney disease population in the United States: a cross-sectional analysis of the national health and nutrition examination survey. Clinical Therapeutics. 37: 188-96. PMID 25524390 DOI: 10.1016/J.Clinthera.2014.11.011 |
0.312 |
|
| 2015 |
Sonawane KB, Hansen RA. Serious adverse Drug events reported to the Food and Drug Administration (FDA): analysis of the FDA adverse event reporting system (FAERS) 2006-2011 database Value in Health. 18. DOI: 10.1016/J.Jval.2015.03.502 |
0.31 |
|
| 2014 |
Hansen RA, Zeng P, Ryan P, Gao J, Sonawane K, Teeter B, Westrich K, Dubois RW. Exploration of heterogeneity in distributed research network drug safety analyses. Research Synthesis Methods. 5: 352-70. PMID 26052957 DOI: 10.1016/J.Jval.2013.03.088 |
0.317 |
|
| 2014 |
Gaynes BN, Lloyd SW, Lux L, Gartlehner G, Hansen RA, Brode S, Jonas DE, Swinson Evans T, Viswanathan M, Lohr KN. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis. The Journal of Clinical Psychiatry. 75: 477-89; quiz 489. PMID 24922485 DOI: 10.4088/Jcp.13R08815 |
0.365 |
|
| 2014 |
Nussbaumer B, Morgan LC, Reichenpfader U, Greenblatt A, Hansen RA, Van Noord M, Lux L, Gaynes BN, Gartlehner G. Comparative efficacy and risk of harms of immediate- versus extended-release second-generation antidepressants: a systematic review with network meta-analysis. Cns Drugs. 28: 699-712. PMID 24794101 DOI: 10.1007/S40263-014-0169-Z |
0.309 |
|
| 2014 |
Reichenpfader U, Gartlehner G, Morgan LC, Greenblatt A, Nussbaumer B, Hansen RA, Van Noord M, Lux L, Gaynes BN. Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a systematic review with network meta-analysis. Drug Safety. 37: 19-31. PMID 24338044 DOI: 10.1007/S40264-013-0129-4 |
0.377 |
|
| 2014 |
Hansen RA, Gray MD, Fox BI, Hollingsworth JC, Gao J, Hollingsworth ML, Carpenter DM. Expert panel assessment of acute liver injury identification in observational data. Research in Social & Administrative Pharmacy : Rsap. 10: 156-67. PMID 23746420 DOI: 10.1016/J.Sapharm.2013.04.012 |
0.328 |
|
| 2013 |
Hansen RA, Farley JF, Maciejewski ML, Ye X, Qian C, Powers B. Real-world utilization patterns and outcomes of colesevelam hcl in the ge electronic medical record. Bmc Endocrine Disorders. 13: 24. PMID 23866087 DOI: 10.1186/1472-6823-13-24 |
0.308 |
|
| 2013 |
Desai RJ, Williams CE, Greene SB, Pierson S, Hansen RA. Anticoagulant medication errors in nursing homes: characteristics, causes, outcomes, and association with patient harm. Journal of Healthcare Risk Management : the Journal of the American Society For Healthcare Risk Management. 33: 33-43. PMID 23861122 DOI: 10.1002/Jhrm.21116 |
0.307 |
|
| 2013 |
Ellis AR, Dusetzina SB, Hansen RA, Gaynes BN, Farley JF, Stürmer T. Confounding control in a nonexperimental study of STAR*D data: logistic regression balanced covariates better than boosted CART. Annals of Epidemiology. 23: 204-9. PMID 23419508 DOI: 10.1016/J.Annepidem.2013.01.004 |
0.491 |
|
| 2013 |
Ellis AR, Dusetzina SB, Hansen RA, Gaynes BN, Farley JF, Stürmer T. Investigating differences in treatment effect estimates between propensity score matching and weighting: a demonstration using STAR*D trial data. Pharmacoepidemiology and Drug Safety. 22: 138-44. PMID 23280682 DOI: 10.1002/Pds.3396 |
0.509 |
|
| 2013 |
Desai RJ, Williams CE, Greene SB, Pierson S, Caprio AJ, Hansen RA. Exploratory evaluation of medication classes most commonly involved in nursing home errors. Journal of the American Medical Directors Association. 14: 403-8. PMID 23273854 DOI: 10.1016/J.Jamda.2012.11.006 |
0.307 |
|
| 2012 |
Dusetzina SB, Weinberger M, Gaynes BN, Farley JF, Sleath B, Hansen RA. Prevalence of bipolar disorder diagnoses and psychotropic drug therapy among privately insured children and adolescents. Pharmacotherapy. 32: 1085-94. PMID 23208835 DOI: 10.1002/Phar.1148 |
0.537 |
|
| 2012 |
Desai RJ, Hansen RA, Rao JK, Wilkins TM, Harden EA, Yuen A, Jonas DE, Roubey R, Jonas B, Gartlehner G, Lux L, Donahue KE. Mixed treatment comparison of the treatment discontinuations of biologic disease-modifying antirheumatic drugs in adults with rheumatoid arthritis. The Annals of Pharmacotherapy. 46: 1491-505. PMID 23092868 DOI: 10.1345/Aph.1R203 |
0.351 |
|
| 2012 |
Dusetzina SB, Farley JF, Weinberger M, Gaynes BN, Sleath B, Hansen RA. Treatment use and costs among privately insured youths with diagnoses of bipolar disorder. Psychiatric Services (Washington, D.C.). 63: 1019-25. PMID 22855210 DOI: 10.1176/Appi.Ps.201100516 |
0.499 |
|
| 2012 |
Hansen RA, Maciejewski M, Yu-Isenberg K, Farley JF. Adherence to antipsychotics and cardiometabolic medication: association with health care utilization and costs. Psychiatric Services (Washington, D.C.). 63: 920-8. PMID 22706887 DOI: 10.1176/Appi.Ps.201100328 |
0.308 |
|
| 2012 |
Gartlehner G, Thaler K, Hill S, Hansen RA. How should primary care doctors select which antidepressants to administer? Current Psychiatry Reports. 14: 360-9. PMID 22648236 DOI: 10.1007/S11920-012-0283-X |
0.341 |
|
| 2012 |
Thaler KJ, Morgan LC, Van Noord M, Gaynes BN, Hansen RA, Lux LJ, Krebs EE, Lohr KN, Gartlehner G. Comparative effectiveness of second-generation antidepressants for accompanying anxiety, insomnia, and pain in depressed patients: a systematic review. Depression and Anxiety. 29: 495-505. PMID 22553134 DOI: 10.1002/Da.21951 |
0.324 |
|
| 2012 |
Katz AJ, Dusetzina SB, Farley JF, Ellis AR, Gaynes BN, Castillo WC, Stürmer T, Hansen RA. Distressing adverse events after antidepressant switch in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial: influence of adverse events during initial treatment with citalopram on development of subsequent adverse events with an alternative antidepressant. Pharmacotherapy. 32: 234-43. PMID 22392456 DOI: 10.1002/J.1875-9114.2011.01020.X |
0.564 |
|
| 2012 |
Gaynes BN, Dusetzina SB, Ellis AR, Hansen RA, Farley JF, Miller WC, Stürmer T. Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D. Journal of Clinical Psychopharmacology. 32: 114-9. PMID 22198447 DOI: 10.1097/Jcp.0B013E31823F705D |
0.566 |
|
| 2012 |
Hansen RA, Dusetzina SB, Ellis AR, Stürmer T, Farley JF, Gaynes BN. Risk of adverse events in treatment-resistant depression: propensity-score-matched comparison of antidepressant augment and switch strategies. General Hospital Psychiatry. 34: 192-200. PMID 22079151 DOI: 10.1016/J.Genhosppsych.2011.10.001 |
0.553 |
|
| 2011 |
Dusetzina SB, Gaynes BN, Weinberger M, Farley JF, Sleath B, Hansen RA. Receipt of guideline-concordant pharmacotherapy among children with new diagnoses of bipolar disorder. Psychiatric Services (Washington, D.C.). 62: 1443-9. PMID 22193791 DOI: 10.1176/Appi.Ps.000452011 |
0.537 |
|
| 2011 |
Gartlehner G, Hansen RA, Morgan LC, Thaler K, Lux L, Van Noord M, Mager U, Thieda P, Gaynes BN, Wilkins T, Strobelberger M, Lloyd S, Reichenpfader U, Lohr KN. Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis. Annals of Internal Medicine. 155: 772-85. PMID 22147715 DOI: 10.7326/0003-4819-155-11-201112060-00009 |
0.4 |
|
| 2011 |
Gaynes BN, Farley JF, Dusetzina SB, Ellis AR, Hansen RA, Miller WC, Stürmer T. Does the presence of accompanying symptom clusters differentiate the comparative effectiveness of second-line medication strategies for treating depression? Depression and Anxiety. 28: 989-98. PMID 21898717 DOI: 10.1002/Da.20898 |
0.541 |
|
| 2011 |
Farley JF, Wang CC, Hansen RA, Voils CI, Maciejewski ML. Continuity of antipsychotic medication management for Medicaid patients with schizophrenia. Psychiatric Services (Washington, D.C.). 62: 747-52. PMID 21724787 DOI: 10.1176/Ps.62.7.Pss6207_0747 |
0.314 |
|
| 2011 |
Thaler KJ, Noord MV, Morgan LC, Gaynes BN, Lux LJ, Krebs EE, Hansen RA, Gartlehner G. P-504 - The comparative effectiveness of second-generation antidepressants for the accompanying symptoms of depression: a systematic review European Psychiatry. 27: 1. DOI: 10.1016/S0924-9338(12)74671-0 |
0.346 |
|
| 2011 |
Noord MV, Gartlehner G, Hansen R, Morgan L, Thaler K, Lux L, Mager U, Gaynes B, Thieda P, Strobelberger M, Lloyd S, Reichenpfader U, Lohr K. P-536 - Immediate-release and extended-release formulations of second-generation antidepressants for the treatment of major depressive disorder in adults European Psychiatry. 26: 1289-1289. DOI: 10.1016/S0924-9338(11)72994-7 |
0.32 |
|
| 2010 |
Chen SY, Hansen RA, Gaynes BN, Farley JF, Morrissey JP, Maciejewski ML. Guideline-concordant antidepressant use among patients with major depressive disorder. General Hospital Psychiatry. 32: 360-7. PMID 20633739 DOI: 10.1016/J.Genhosppsych.2010.03.007 |
0.341 |
|
| 2010 |
Crespin DJ, Modi AV, Wei D, Williams CE, Greene SB, Pierson S, Hansen RA. Repeat medication errors in nursing homes: Contributing factors and their association with patient harm. The American Journal of Geriatric Pharmacotherapy. 8: 258-70. PMID 20624615 DOI: 10.1016/J.Amjopharm.2010.05.005 |
0.302 |
|
| 2010 |
Maciejewski ML, Farley JF, Hansen RA, Wei D, Harman JS. Part D plan enrollment by uninsured medicare beneficiaries. Medical Care. 48: 183-6. PMID 20057332 DOI: 10.1097/Mlr.0B013E3181Bd4E0A |
0.345 |
|
| 2010 |
Chen SY, Hansen RA, Farley JF, Gaynes BN, Morrissey JP, Maciejewski ML. Follow-up visits by provider specialty for patients with major depressive disorder initiating antidepressant treatment. Psychiatric Services (Washington, D.C.). 61: 81-5. PMID 20044424 DOI: 10.1176/Ps.2010.61.1.81 |
0.35 |
|
| 2010 |
Hansen RA, Dusetzina SB, Dominik RC, Gaynes BN. Prescription refill records as a screening tool to identify antidepressant non-adherence. Pharmacoepidemiology and Drug Safety. 19: 33-7. PMID 19998397 DOI: 10.1002/Pds.1881 |
0.496 |
|
| 2010 |
Dusetzina S, Hansen R, Farley J, Weinberger M, Sleath B, Gaynes B. PMH86 AGE RELATED TREATMENT DIFFERENCES AMONG CHILDREN WITH BIPOLAR SPECTRUM DISORDERS Value in Health. 13: A120-A121. DOI: 10.1016/S1098-3015(10)72581-X |
0.481 |
|
| 2009 |
Roth MT, Watson LC, Esserman DA, Ivey JL, Hansen R, Lewis CL, Weinberger M. Methodology of a pilot study to improve the quality of medication use in older adults: Enhancing Quality in Psychiatry Using Pharmacists (EQUIPP). The American Journal of Geriatric Pharmacotherapy. 7: 362-72. PMID 20129257 DOI: 10.1016/J.Amjopharm.2009.11.007 |
0.31 |
|
| 2009 |
Thaler K, Chandiramani DV, Hansen RA, Gartlehner G. Efficacy and safety of anakinra for the treatment of rheumatoid arthritis: an update of the Oregon Drug Effectiveness Review Project. Biologics : Targets & Therapy. 3: 485-98. PMID 20054439 DOI: 10.2147/Btt.2009.3755 |
0.341 |
|
| 2009 |
Hansen RA, Dusetzina SB, Song L, Gaynes BN, Tu W, Murray MD. Depression affects adherence measurement but not the effectiveness of an adherence intervention in heart failure patients. Journal of the American Pharmacists Association : Japha. 49: 760-8. PMID 19926556 DOI: 10.1331/Japha.2009.08184 |
0.533 |
|
| 2009 |
Gartlehner G, Thaler K, Hansen RA, Gaynes BN. The general and comparative efficacy and safety of duloxetine in major depressive disorder: a systematic review and meta-analysis. Drug Safety. 32: 1159-73. PMID 19916583 DOI: 10.2165/11318930-000000000-00000 |
0.369 |
|
| 2009 |
Little A, Hansen RA, Gartlehner G, Gray C. Impact of the STAR*D trial from the perspective of the payer. Psychiatric Services (Washington, D.C.). 60: 1463-5. PMID 19880462 DOI: 10.1176/Ps.2009.60.11.1463 |
0.332 |
|
| 2009 |
Gartlehner G, Thieda P, Hansen RA, Morgan LC, Shumate JA, Nissman DB. Inadequate reporting of trials compromises the applicability of systematic reviews. International Journal of Technology Assessment in Health Care. 25: 323-30. PMID 19619351 DOI: 10.1017/S0266462309990122 |
0.319 |
|
| 2009 |
Hansen RA, Kim MM, Song L, Tu W, Wu J, Murray MD. Comparison of methods to assess medication adherence and classify nonadherence. The Annals of Pharmacotherapy. 43: 413-22. PMID 19261962 DOI: 10.1345/Aph.1L496 |
0.318 |
|
| 2009 |
Hansen RA, Moore CG, Dusetzina SB, Leinwand BI, Gartlehner G, Gaynes BN. Controlling for drug dose in systematic review and meta-analysis: a case study of the effect of antidepressant dose. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 29: 91-103. PMID 19141788 DOI: 10.1177/0272989X08323298 |
0.717 |
|
| 2009 |
Hansen R, Farley J, Droege M, Maciejewski M. PDB10 A COMPARISON OF ECONOMIC OUTCOMES BETWEEN ADHERENT AND NONADHERENT PATIENTS TREATED WITH ORAL ANTIDIABETIC MEDICATIONS Value in Health. 12: A98. DOI: 10.1016/S1098-3015(10)73554-3 |
0.319 |
|
| 2008 |
Gartlehner G, Gaynes BN, Hansen RA, Thieda P, DeVeaugh-Geiss A, Krebs EE, Moore CG, Morgan L, Lohr KN. Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians. Annals of Internal Medicine. 149: 734-50. PMID 19017592 DOI: 10.7326/0003-4819-149-10-200811180-00008 |
0.394 |
|
| 2008 |
Hansen R, Gaynes MPHB, Thieda P, Gartlehner MPHG, Deveaugh-Geiss A, Krebs E, Lohr K. Meta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressants. Psychiatric Services. 59: 1121-1130. PMID 18832497 DOI: 10.1176/Appi.Ps.59.10.1121 |
0.326 |
|
| 2008 |
Krebs EE, Gaynes BN, Gartlehner G, Hansen RA, Thieda P, Morgan LC, DeVeaugh-Geiss A, Lohr KN. Treating the physical symptoms of depression with second-generation antidepressants: a systematic review and metaanalysis. Psychosomatics. 49: 191-8. PMID 18448772 DOI: 10.1176/Appi.Psy.49.3.191 |
0.307 |
|
| 2008 |
Hansen RA, Gaynes BN, Gartlehner G, Moore CG, Tiwari R, Lohr KN. Efficacy and tolerability of second-generation antidepressants in social anxiety disorder. International Clinical Psychopharmacology. 23: 170-9. PMID 18408531 DOI: 10.1097/Yic.0B013E3282F4224A |
0.326 |
|
| 2008 |
Donahue KE, Gartlehner G, Jonas DE, Lux LJ, Thieda P, Jonas BL, Hansen RA, Morgan LC, Lohr KN. Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis. Annals of Internal Medicine. 148: 124-34. PMID 18025440 DOI: 10.7326/0003-4819-148-2-200801150-00192 |
0.359 |
|
| 2008 |
Gartlehner G, Hansen RA, Jonas BL, Thieda P, Lohr KN. Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and critical analysis of the evidence. Clinical Rheumatology. 27: 67-76. PMID 17570009 DOI: 10.1007/S10067-007-0654-6 |
0.329 |
|
| 2007 |
Fu AZ, Liu GG, Christensen DB, Hansen RA. Effect of second-generation antidepressants on mania- and depression-related visits in adults with bipolar disorder: a retrospective study. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 10: 128-36. PMID 17391421 DOI: 10.1111/J.1524-4733.2006.00159.X |
0.303 |
|
| 2007 |
Hansen RA, Gartlehner G, Lohr KN, Kaufer DI. Functional outcomes of drug treatment in Alzheimer's disease: A systematic review and meta-analysis. Drugs & Aging. 24: 155-67. PMID 17313203 DOI: 10.2165/00002512-200724020-00007 |
0.347 |
|
| 2007 |
Hansen R, Seifeldin R, Noe L. Php25 Medication Adherence In Post-Transplant Immunosuppression:The Economic Impact Of Drug-Regimen Complexity Value in Health. 10. DOI: 10.1016/S1098-3015(10)65303-X |
0.3 |
|
| 2007 |
Gartlehner G, Hansen R, Thieda P, Gaynes B, DeVeaugh-Geiss A, Krebs E, Lohr K. Pmh5 The Comparative Efficacy Of Second-Generation Antidepressants Forthe Acute-Phase Treatment Of Major Depressive Disorder: A Systematic Review And Meta-Analysis Value in Health. 10. DOI: 10.1016/S1098-3015(10)65055-3 |
0.32 |
|
| 2006 |
Fu AZ, Christensen DB, Hansen RA, Liu GG. Second-generation antidepressant discontinuation and depressive relapse in adult patients with bipolar depression: results of a retrospective database analysis. Clinical Therapeutics. 28: 979-89. PMID 16860180 DOI: 10.1016/J.Clinthera.2006.06.011 |
0.319 |
|
| 2006 |
Gartlehner G, Hansen RA, Carson SS, Lohr KN. Efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomes. Annals of Family Medicine. 4: 253-62. PMID 16735528 DOI: 10.1370/Afm.517 |
0.342 |
|
| 2005 |
Schommer JC, Singh RL, Hansen RA. Distinguishing characteristics of patients who seek more information or request a prescription in response to direct-to-consumer advertisements. Research in Social & Administrative Pharmacy : Rsap. 1: 231-50. PMID 17138476 DOI: 10.1016/J.Sapharm.2005.03.009 |
0.301 |
|
| 2005 |
Hansen RA, Schommer JC, Cline RR, Hadsall RS, Schondelmeyer SW, Nyman JA. The association of consumer cost-sharing and direct-to-consumer advertising with prescription drug use. Research in Social & Administrative Pharmacy : Rsap. 1: 139-57. PMID 17138472 DOI: 10.1016/J.Sapharm.2005.03.002 |
0.302 |
|
| 2005 |
Blalock SJ, Byrd JE, Hansen RA, Yamanis TJ, McMullin K, DeVellis BM, DeVellis RF, Panter AT, Kawata AK, Watson LC, Jordan JM. Factors associated with potentially inappropriate drug utilization in a sample of rural community-dwelling older adults. The American Journal of Geriatric Pharmacotherapy. 3: 168-79. PMID 16257819 DOI: 10.1016/S1543-5946(05)80023-6 |
0.361 |
|
| 2005 |
Hansen RA, Gartlehner G, Lohr KN, Gaynes BN, Carey TS. Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder. Annals of Internal Medicine. 143: 415-26. PMID 16172440 DOI: 10.7326/0003-4819-143-6-200509200-00006 |
0.388 |
|
| 2005 |
Gartlehner G, Hansen RA, Carey TS, Lohr KN, Gaynes BN, Randolph LC. Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis. International Clinical Psychopharmacology. 20: 59-69. PMID 15729080 DOI: 10.1097/00004850-200503000-00001 |
0.382 |
|
| Show low-probability matches. |